Sentence examples for mice with subcutaneous from inspiring English sources

In a previous imaging study, we demonstrated the feasibility of pretargeted immuno-PET using 68Ga- or 18F-labeled di-HSG peptides in mice with subcutaneous tumors [32].

As shown in Fig. 22a c, bright spot of Ag2S QDs fluorescence was observed in the mice with subcutaneous and celiac injection compared with the ordinary mice.

Biodistribution and tumour targeting of the 111In-labelled PP-F11 were studied in female athymic BALB/c mice with subcutaneous tumours induced by inoculation of A431 cells.

Figure 4 Biodistribution of 68 Ga-Ex4NOD12, 68 Ga-Ex4NOD27 and 68 Ga-Ex4NOD40 in CD1 nu/nu mice with subcutaneous CHL-GLP-1R-positive tumours.

The noninvasive visualization of nude mice with subcutaneous injection indicates that the Eu3+/Gd3+−CaP vesicle-like nanospheres are suitable for in vivo bio-imaging.

Furthermore, the noninvasive visualization of nude mice with subcutaneous injection indicates that the Eu3+/Gd3+-doped HAp nanorods with the photoluminescent function are suitable for in vivo imaging.

b The left side: the optical image of the nude mouse with subcutaneous injection.

[11C]Erlotinib PET/CT scans were carried out in athymic nude mice grafted with subcutaneous (s.c).

In vivo MR imaging was performed on nude mice loaded with subcutaneous gastric cancer at 12 h post-injection.

In mice treated with subcutaneous infusion of 1 mg/kg PYY3-36, it was similarly shown that RQ was decreased during the dark cycle, although the effect was transient.

Interestingly, it has recently been reported that TLR3 stimulation of dermal fibroblasts increased the expression of IFNα2- and TGF-β-responsive genes and that mice treated with subcutaneous TLR3 agonists developed dermal inflammation followed by fibrosis [ 42].